— Know what they know.
Not Investment Advice

Financial News

Sentiment 46.2 5304 articles 2881 bullish 1233 bearish Full Index →
📰

GUERBET : Mise à disposition du Document d’enregistrement universel 2025

Mise à disposition du Document d’enregistrement universel 2025
📰

The Zacks Analyst Blog Highlights Procter & Gamble, UnitedHealth, Wells Fargo and Seneca Foods

Procter & Gamble, UnitedHealth, and Wells Fargo face near-term pressure, but steady sales, growth initiatives, and strong cash flows support...
📰

Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?

Here is how Aura Biosciences, Inc. (AURA) and Elicio Therapeutics (ELTX) have performed compared to their sector so far this year.
📰

Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?

Here is how Aura Biosciences, Inc. (AURA) and Elicio Therapeutics (ELTX) have performed compared to their sector so far this year.
5W PR Delivers High-Impact PR Strategies for B2B Companies N

5W PR Delivers High-Impact PR Strategies for B2B Companies Navigating Competitive and Emerging Industries

NEW YORK, March 20, 2026 /PRNewswire/ -- 5W PR, one of the largest independently owned PR firms in the U.S., today announced the launch of its...
How To Spot An AI Tax Scam This Filing Season

How To Spot An AI Tax Scam This Filing Season

Tax scams are growing more sophisticated this filing season, with artificial intelligence giving fraudsters new tools to impersonate government...
Investors Heavily Search Tenet Healthcare Corporation (THC):

Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Tenet (THC). This makes it worthwhile to examine what the stock has in store.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Here is What to Know Beyond Why Bristol Myers Squibb Company

Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock

Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's...
📰
📰
📰

BioLineRx FY 2025 Earnings Preview

📰

RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET

MOUNTAIN VIEW, Calif., March 20, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. ("RenovoRx" or the "Company") (NASDAQ:RNXT), a life sciences company...
📰

TMYTEK and Comtech Join Forces to Enable Ubiquitous Connectivity through Next Generation of Multi-Orbit Distributed SATCOM Network User Terminals

TAIPEI, March 20, 2026 /PRNewswire/ -- TMY Technology Inc. (TMYTEK) unveiled advanced user terminal solutions for next-generation satellite...
📰

Is CRISPR Therapeutics Stock a Buy Now?

We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.
📰

Picard Medical / SynCardia to Present its Next-Generation Emperor Total Artificial Heart Technology at the American College of Cardiology's Annual Scientific Session

TUCSON, Ariz., March 20, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) (the "Company"), parent company of SynCardia Systems LLC, maker...
📰

5 Companies At the Center of America's Rare-Earth Revival

FN Media Group Presents Oilprice.com Market Commentary NEW YORK, March 20, 2026 /PRNewswire/ -- Six companies are quietly rebuilding one of the most...
📰

iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference

NASHVILLE, Tenn., March 20, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (NASDAQ:IMDX), (iMDx), today announced that it will report...
📰

Picard Medical / SynCardia to Present its Next-Generation Emperor Total Artificial Heart Technology at the American College of Cardiology’s Annual Scientific Session

Poster presentation and conference exhibit will feature early preclinical data on the Company’s fully implantable, autoregulating artificial heart...
📰

Is CRISPR Therapeutics Stock a Buy Now?

We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.
Earnings Scheduled For March 20, 2026

Earnings Scheduled For March 20, 2026

Companies Reporting Before The Bell • BitFuFu (NASDAQ:FUFU) is likely to report quarterly earnings at $0.01 per share on revenue of $105.15 million....
📰

Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer

Thomas A. Zalewski, a Partner at Day Pitney LLP, appointed Chief Legal Officer and Chief Compliance Officer effective April 2, 2026 Lori J. Braender...
📰

Foundation Consumer Healthcare Sells Portion of Consumer Health Business

PITTSBURGH, March 20, 2026 (GLOBE NEWSWIRE) -- Foundation Consumer Healthcare (FCH) announced today that it has entered into a definitive agreement...
Bionano Genomics Earnings Are Imminent; These Most Accurate

Bionano Genomics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Bionano Genomics, Inc. (NASDAQ:BNGO) will release earnings results for its fourth quarter, after the closing bell on Monday, March 23. Analysts...
Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are Th

Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) will release earnings for its fourth quarter before the opening bell on Friday, March 20. Analysts...
Social supermarket praise for Comic Relief support

Social supermarket praise for Comic Relief support

Yvonne Smith says "things were desperate" when she signed up to the Plate of Plenty in Nuneaton.
📰

How Investors Are Reacting To Sarepta Therapeutics (SRPT) Pushing Duchenne Drugs Toward Full FDA Approval - simplywall.st

How Investors Are Reacting To Sarepta Therapeutics (SRPT) Pushing Duchenne Drugs Toward Full FDA Approval  simplywall.st
📰

BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

SUNNYVALE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics...
📰

Nyxoah (NYXH) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.Thursday, March 19, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰

Cellectis publie ses résultats financiers du quatrième trimestre 2025 et de l’exercice 2025 et une mise à jour de ses activités

NEW YORK, 20 mars 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui...
📰

Cellectis Reports Full Year 2025 Financial Results and Provides a Business Update

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology...
📰

Tenon Medical (TNON) Q4 2025 Earnings Transcript

Image source: The Motley Fool.Thursday, March 19, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰

Relmada (RLMD) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.Thursday, Mar. 19, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰

electroCore (ECOR) Q4 2025 Earnings Transcript

Image source: The Motley Fool.Thursday, March 19, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

ROSEN, A LEADING LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰
📰

Eton Pharma (ETON) Earnings Call Transcript

Image source: The Motley Fool.Thursday, March 19, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰
📰

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

MISSISSAUGA, Ontario, March 19, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (("BioSyent", TSXV:RX) released today its financial results for the fourth...
📰

Curis (CRIS) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.Thursday, March 19, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results
📰

Alumis reports FY results

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms